Diagnostic Ultrasound
Molecular Diagnostics Market 2017: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2024
MarketStudyReport.com Adds New Molecular Diagnostics Market 2017 – 2024 research report providing information and By Application, By Technology, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 270 Pages with table and figures in it.
Molecular Diagnostics Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 8.4% CAGR to 2024.
Molecular Diagnostics Market is set to exceed USD 12.5 billion by 2024; according to a new research report. Growing geriatric population base along with rising incidences of infectious diseases will act as high impact rendering factors for molecular diagnostics market. Elderly people prone to suffer from several diseases require continuous monitoring as well as diagnostic tests for various diseases. Multifactorial benefits and applications of molecular diagnostics in therapeutic monitoring, detection of predisposition to disease, patient stratification, drug regimen selection and others will drive molecular diagnostics market growth.
Technological advancements including target specific PCR, high throughput capacity has escalated level of disease diagnosis in less time as compared to conventional method will favor molecular diagnostics market growth. Growing awareness about several diseases, diagnosis and prevention has stimulated demand for diagnostic tests.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467710/
Growing adoption of western culture, unhealthy dietary habits and physical inactivity has led to upsurge in several chronic disease incidences. Increasing prevalence of infectious diseases in developing countries such as India coupled with growing demand for point of care diagnostic technologies (POCT) will fuel business growth.
Growth of home healthcare sector coupled with technological advancements in handheld POCT devices will drive molecular diagnostics market growth. Rising demand for cost effective disease diagnostic tests has accelerated rise in R&D investment for development of molecular diagnostic platform. Significant role of molecular testing in diagnosis of cancer and sexually transmitted disease will positively impact industry growth. However, complex nature of U.S. FDA approval for molecular diagnostic technology coupled with rising costs associated with molecular testing will hinder molecular diagnostics market growth over the forecast period.
Infectious disease segment held largest revenue share in 2016 and is expected to follow similar trend over the forecast timeframe due to increasing incidences of infectious diseases in developing countries of Asia Pacific and Latin America. Growing awareness about pre-disease diagnosis will fuel molecular diagnostics market growth.
U.S. molecular diagnostics market held largest revenue share in 2016 due to growing geriatric population, highly susceptible to suffer from various illnesses along with high technological adoption rate of U.S. Increasing healthcare expenditure by government as well as individual will positively impact market growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467710/
China molecular diagnostics market should grow at significant rate due to growing demand for advanced treatment coupled with rising prevalence of infectious diseases such as hepatitis in the country. Increasing number of baby boomers will act as primary driver for industry growth. Increasing focus of industry players towards expanding country’s molecular diagnostics platform coupled with rising adoption of PCR and locally manufactured diagnostic kits in the country will favor Chine molecular diagnostics market growth.
Some of the key industry players operating in global molecular diagnostics market are Abbott, Alere, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Danaher Corporation, GenMark Diagnostics, HTG Molecular Diagnostics, Johnson & Johnson, MDxHealth, Novartis (Grifols), Qiagen Gaithersburg, Siemens Healthcare and Roche. Industry players are focusing their efforts towards developing new cost-effective, highly accurate and easy operative molecular diagnostic products to satisfy increasing consumer demand along with consolidate its market position. Strategic partnership, alliances, mergers and acquisitions are major strategies followed by market players.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Molecular Diagnostics Industry Insights
Chapter 4. Molecular Diagnostics Market, By Application
Chapter 5. Molecular Diagnostics Market, By Technology
Chapter 6. Molecular Diagnostics Market, By Region
Chapter 7. Company Profiles
For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html
Related Report:
Global In Vitro Diagnostics (IVDs) Market Research Report 2018
This report studies the global In Vitro Diagnostics (IVDs) market status and forecast, categorizes the global In Vitro Diagnostics (IVDs) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Diagnostic Ultrasound Market: Industry Growth Factors, Applications, Regional Analysis, Key Players and Forecasts by 2024
MarketStudyReport.com Adds New Diagnostic Ultrasound Market 2017 – 2024 research report providing information and By Technology, By Application, By End use, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 120 Pages with table and figures in it.
Diagnostic Ultrasound Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 3% CAGR to 2024.
Diagnostic Ultrasound Market is set to exceed USD 7 billion by 2024; according to a new research report. Growing geriatric population base along with increasing chronic disease incidence rates will drive diagnostic ultrasound market growth over the forecast period. Higher susceptibility of the elderly towards certain orthopedic ailments and chronic diseases will boost ultrasound demand as the technology facilitates management of these disease conditions on an ongoing basis. For instance, a patient with prostatic hypertrophy started on certain medications which could possibly worsen bladder emptying can be monitored with ultrasound after initiation of medication.
Ultrasound devices are witnessing a transition from trolley based, single use systems to highly portable, versatile and multiuse systems. Rapid technological advancements in microelectronics and sensors coupled with improvement in image quality and expansion of applications will propel ultrasound system adoption rates
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/716649/
Dearth of skilled ultrasound technicians and sonographers especially in countries such as UK and Canada hinder industry expansion. Lack of availability of these skilled professionals is resulting in increased patient waiting time for ultrasound examinations and underuse of the equipment.
Existence of barriers such as lack of training, high machine maintenance cost, absence of support personnel, lack of gel, irregular electrical supply, discomfort in image interpretation and liability concerns hamper technology adoption in developing countries.2D technology held significant industry share in 2016 being the most common and traditional method used for scanning. The technology produces a series of flat, two-dimensional image of the scanned tissue. Increasing usage of newer technologies such as 3D, 4D and 5D which provide a more detailed and realistic image as compared to 2D will impede segment growth.
Compact or handheld ultrasound devices segment will grow at the fastest pace during the forecast period as they offer greater convenience due to their small and light weight. Furthermore, they are highly beneficial for medical professionals practicing in acute care settings where transportation of the patient may be difficult owing to the constantly changing health condition.
Application of the technology in cardiology held significant industry share. Increasing number of people suffering from cardiovascular diseases such as stroke will drive segment growth over the forecast timeframe.
Hospitals end user segment is slated to grow at a robust rate owing to increasing influx of patients undergoing ultrasound scans in these settings. Expansion of hospitals and development of new ones will further spur growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/716649/
China diagnostic ultrasound market held significant industry share. Increasing healthcare expenditure, growing disease burden along with increasing desire for and utilization of more advanced technologies in healthcare facilities will drive industry growth.
Prominent industry players include GE Healthcare, Samsung, Hitachi, Siemens, Koninklijke Philips N.V., Toshiba, SIUI, Promed Group, TELEMED Medical, Mindray and Esaote. The industry participants adopt various strategies such as acquisitions, new product development and launch for expanding their industry foothold. For instance, in March 2016, Mindray launched Resona 7 in Europe.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Diagnostic Ultrasound Industry Insights
Chapter 4. Diagnostic Ultrasound Market, By Application
Chapter 5. Diagnostic Ultrasound Market, By Technology
Chapter 6. Diagnostic Ultrasound Market, By End use
Chapter 7. Diagnostic Ultrasound Market, By Region
Chapter 8. Company Profiles
For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html
Related Report:
United States Diagnostic Ultrasound Imaging System Market Report 2018
In this report, the United States Diagnostic Ultrasound Imaging System market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Prenatal and New-born Genetic Testing Market Trend to 2024 Profiling Ariosa Diagnostics, Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom & More
MarketStudyReport.com Adds New Prenatal and New-born Genetic Testing Market 2018 – 2024 research report providing information and By Technology, By Disease, By End-use, Industry Analysis, By Technology, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 140 Pages with table and figures in it.
Prenatal and New-born Genetic Testing Market Research Report for the period of 2018-2024 that shows the growth of the market is rising at a 11.9% CAGR to 2024.
Prenatal and New-born Genetic Testing Market will exceed USD 7 billion by 2024; as per a new research report. Technological advancement and several benefits associated with infant genetic testing will be major driver of the prenatal and new-born genetic testing market. Introduction of prenatal testing has led to substantial amount of increase in adoption rate of new testing technologies such as non-invasive prenatal testing (NIPT) for detection of sub chromosomal abnormalities, single-gene disorders and aneuploidy in North America region. Inclination towards minimally invasive infant genetic testing along with demand for early detection of birth defects will one of the major reason for market growth.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1130963/
Rising number of consanguineous relations in the developing countries of Asia and Middle East will foster growth opportunities for prenatal and newborn genetic testing market. The consanguineous relations are responsible for births of infants with defects and chromosomal abnormalities. Consequent, the increase in cases of live births diagnosed with birth defects will directly impact the growth of prenatal and new-born genetic testing market.
Increasing prevalence of birth defects among the European population is one of the major reason for rising infant mortality. The necessary government initiatives in order to conduct prenatal and new-born genetic tests to diagnose the birth defects will increase the number of infant screening programs giving rise to market growth opportunities.
Screening technology holds majority of market share in the year 2017 owing to increasing number of screening procedures of pregnant women while delivery. The rise in awareness among the families regarding genetic birth defects and early detection of genetic disorder will augment the segment growth in the near future.
Downs Syndrome recorded largest market share in the prenatal and newborn genetic testing market due to increasing in number of births diagnosed with Downs syndrome. The rise in incidences of women getting married at later stage of life is leading to increasing births with Downs Syndrome. These factors will further support the segment growth over the forecast timeframe.
Hospitals hold the majority of market share owing to increasing number of births in hospitals. Hospitals are aided by the government and provide the facilities require for the newborn screening. The increase in number of screening programs in hospitals provides significant scope for the market growth.
U.S. dominated the market in 2017 owing to ongoing technological advancements along with favorable reimbursement policies. The U.S. region had 99% of newborn screening rate and high awareness about prenatal and new-born genetic testing will be responsible for the market growth in U.S. Presence of technologically advanced and equipped manufacturing companies along with government initiatives supporting screening activities that will impel market growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1130963/
Some of the major market players competing in global prenatal and newborn genetic testing market are Ariosa Diagnostics (Roche), Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom, Trivitron Healthcare and Verinata health. The competitors are using launch of novel products with technological advancements, acquisitions and mergers as the key strategies to foresee a lucrative growth in prenatal and newborn genetic testing market. For example, In March 2018, Natera declared a partnership with QIAGEN to develop cell-free DNA assays for QIAGEN’s GeneReader NGS System. These DNA assays will be developed and designed for tests, including prenatal screening, for laboratories and hospitals globally.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Prenatal and New-born Genetic Testing Industry Insights
Chapter 4. Prenatal and New-born Genetic Testing Market, By Technology
Chapter 5. Prenatal and New-born Genetic Testing Market, By Disease
Chapter 6. Prenatal and New-born Genetic Testing Market, By End-use
Chapter 6. Prenatal and New-born Genetic Testing Market, By Region
Chapter 7. Company Profiles
For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html
Related Report:
Global Prenatal and New-born Genetic Testing Market Size, Status and Forecast 2025
This report studies the global Prenatal and New-born Genetic Testing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Prenatal and New-born Genetic Testing market by companies, region, type and end-use industry.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Point of Care Molecular Diagnostics Market Size, Share, Trend & Growth Forecast to 2024
MarketStudyReport.com Adds New Point of Care (PoC) Molecular Diagnostics Market 2017 – 2024 research report providing information and By Technology, By Infectious Diseases, Industry Analysis, Regional Outlook, Growth Potential, Trends, Competitive Market Share & Forecast spreading across 150 Pages with table and figures in it.
Point of Care (PoC) Molecular Diagnostics Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 9% CAGR to 2024.
Increasing awareness regarding pre-disease diagnosis along with growing incidence of infectious diseases will drive POC molecular diagnostics market growth. Growing R&D focused on reducing time required for molecular tests will further propel industry growth. However, long product development time and complex regulatory process will hamper the business acceleration. Global point of care (PoC) molecular diagnostics market is set to exceed USD 2.5 billion by 2024, according to this new research report.
Isothermal amplification technology should exhibit lucrative growth as they are used as an alternative to polymerase chain reaction. Thermocycling machines are not required in the use of this technology and it can mostly be performed with reduced time, greater accuracy and high throughput. The increased reliability of isothermal amplification will drive segment growth. The added benefit of constant temperature of amplification provides a high potential for simple integration of this technique in PoC devices.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/707351/
Sequencing technology are poised to grow at the fastest pace as ongoing advancements and increase in sequencing throughput have considerably decreased both sequencing costs and time.
Point of care molecular diagnostics for Clostridium difficile will witness robust growth in the coming years. In the developed countries, Clostridium infection is the most common cause of nosocomial infectious diarrhea. Growing use of PoC test owing to feasibility, performance ease and acceptability will fuel demand.
Growing demand for accurate and inexpensive PoC tests for controlling sexually transmitted infections along with need for immediate patient diagnosis and treatment will drive point of care molecular diagnostics for Gonorrhea.
India point of care molecular diagnostics market is slated to experience rapid growth over the forecast years. Increasing burden of various infectious diseases such as HIV, Tuberculosis, Hepatitis and Influenza will stimulate demand. PoC diagnostic testing is at its nascent stage in the country with tests being available for certain diseases. The industry is anticipated to witness significant growth over the coming years.
Mexico point of care molecular diagnostics market will witness considerable growth over the forecast timeframe owing to the increasing focus to deliver low cost care to the patient’s home. Increasing volume of point of care molecular testing will further stimulate demand. Growing efforts to provide effective care for infectious diseases along with easy to use devices will augment industry expansion.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/707351/
Some of the prominent industry players include Abbott, Sysmex, Roche, Bayer, Danaher, BioMerieux and Bio-Rad Laboratories. Presently, there are few companies operating in the industry, however, the rivalry will intensify in the coming years with the entry of new players. The industry participants adopt various strategic initiatives such as launching of new products, geographical expansion and acquisitions to consolidate their market position. For instance, in July 2017, OraSure Technologies received prequalification from WHO for its OraQuick HIV Self- Test. The company also recently entered into an agreement with Bill & Melinda Gates Foundation for reducing the price of the test in 50 developing countries. Both the aforementioned strategies would accelerate adoption and deployment of the test.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Point of Care (PoC) Molecular Diagnostics Industry Insights
Chapter 4. Point of Care (PoC) Molecular Diagnostics Market, By Technology
Chapter 5. Point of Care (PoC) Molecular Diagnostics Market, By Infectious Disease
Chapter 6. Point of Care (PoC) Molecular Diagnostics Market, By Region
Chapter 7. Company Profiles
For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html
Related Report:
United States Diagnostic Ultrasound Imaging System Market Report 2018
In this report, the United States Diagnostic Ultrasound Imaging System market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
In-Vitro Colorectal Cancer Screening Tests Market Trend to 2024 Profiling Qiagen, Beckman Coulter, Siemens Healthcare, EMD Millipore, Alere, Abbott Molecular, Quest Diagnostics & more
The 2017-2024 report on global In-Vitro Colorectal Cancer Screening Tests market explores the essential factors of In-Vitro Colorectal Cancer Screening Tests industry covering current scenario, market demand information, coverage of active companies and segmentation forecasts.
In-Vitro Colorectal Cancer Screening Tests Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a 5% CAGR to 2024.
In-Vitro Colorectal Cancer Screening Tests market will exceed USD 1 billion by 2024; as per a new research report.Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.
Growing adoption of sedentary lifestyle, unhealthy dietary habits along with increased tobacco smoking and alcohol consumption has escalated number of people suffering from inflammatory intestinal conditions. Thus, leading to rise in colorectal cancer cases. Numerous initiatives undertaken by public as well as private players to create awareness about pre-diagnosis and treatment of colon and rectal cancer will favor industry growth.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467720/
Technological advancements in cancer screening tests delivering higher precision, accuracy in less time coupled with favorable reimbursement policies for colorectal cancer screening in developed countries such as U.S. will stimulate industry growth. However, lack of colorectal cancer screening guidelines and reimbursement in developing countries of Asia Pacific will hamper in-vitro colorectal cancer screening tests market growth over the forecast period.
Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness along with rising demand for non-invasive cancer screening tests will further fuel business growth.
High prevalence of colorectal cancer in the U.S., favorable reimbursement policies and technological advancements in cancer screening will drive U.S. in-vitro colorectal cancer screening tests market over the coming years. High adoption of unhealthy diet along with physical inactivity has led to rise in number of people suffering from chronic conditions such as obesity will propel business growth. Non-Hispanic Blacks and Alaskan citizens living in U.S., are at substantial risk of suffering from colorectal cancer will stimulate demand for invitro colorectal cancer screening tests.
Germany in-vitro colorectal cancer screening tests market was dominating the industry owing to large patient population and growing adoption of screening tests for preventing bowel cancer in the country. Changing lifestyle and food consumption pattern will positively impact market growth. Moreover, high technological adoption and favorable reimbursement policies for cancer screening will favor Germany in-vitro colorectal cancer screening tests market growth.
Several initiatives undertaken by Chinese government to create awareness about colorectal cancer to reduce disease burden coupled with rising number of baby boomers will drive China in-vitro colorectal cancer screening tests market. Growing disposable income and rendering unmet medical needs in the country will further stimulate business growth over the coming years.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467720/
Some of the notable industry players are Qiagen, Beckman Coulter, Siemens Healthcare, EMD Millipore, Alere, Abbott Molecular, Quest Diagnostics and Sysmex Corporation among others.
Major industry players are focusing on developing superior non-invasive techniques for screening of colorectal cancer to gain significant market share as well as sustain its position in the market. Inorganic growth strategies such as merger and acquisition, along with strategic partnership and collaboration are undertaken by industry players to strengthen product portfolio and expand customer base.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. In-Vitro Colorectal Cancer Screening Tests Industry Insights
Chapter 4. In-Vitro Colorectal Cancer Screening Tests Market, By Test Type
Chapter 5. In-Vitro Colorectal Cancer Screening Tests Market, By Region
Chapter 6. Company Profiles
For More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html
Related Report:
Global In-vitro Colorectal Cancer Screening Tests Market Size, Status and Forecast 2025
In 2017, the global In-vitro Colorectal Cancer Screening Tests market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Molecular Diagnostics Market to See 8.4% CAGR Growth to 2024: Growth Factor & Trends
MarketStudyReport.com adds a new Molecular Diagnostics Market research report that provides a detailed market overview as well as industry analysis for / of companies, manufacturers and distributors covering data on gross margin, cost structure, consumption value, sale price and more.
Growing geriatric population base along with rising incidences of infectious diseases will act as high impact rendering factors for Molecular Diagnostics Market. Elderly people prone to suffer from several diseases require continuous monitoring as well as diagnostic tests for various diseases. Multifactorial benefits and applications of molecular diagnostics in therapeutic monitoring, detection of predisposition to disease, patient stratification, drug regimen selection and others will drive molecular diagnostics market growth.
Request a sample copy of Molecular Diagnostics Market Research Report @ https://www.marketstudyreport.com/request-a-sample/467710/?utm_source=WP-SK
Molecular Diagnostics Market is set to exceed USD 12.5 billion by 2024; according to a new research report.
Technological advancements including target specific PCR, high throughput capacity has escalated level of disease diagnosis in less time as compared to conventional method will favor molecular diagnostics market growth. Growing awareness about several diseases, diagnosis and prevention has stimulated demand for diagnostic tests.
Growing adoption of western culture, unhealthy dietary habits and physical inactivity has led to upsurge in several chronic disease incidences. Increasing prevalence of infectious diseases in developing countries such as India coupled with growing demand for point of care diagnostic technologies (POCT) will fuel business growth.
Growth of home healthcare sector coupled with technological advancements in handheld POCT devices will drive molecular diagnostics market growth. Rising demand for cost effective disease diagnostic tests has accelerated rise in R&D investment for development of molecular diagnostic platform. Significant role of molecular testing in diagnosis of cancer and sexually transmitted disease will positively impact industry growth. However, complex nature of U.S. FDA approval for molecular diagnostic technology coupled with rising costs associated with molecular testing will hinder molecular diagnostics market growth over the forecast period.
Enquire about this report @ https://www.marketstudyreport.com/enquiry-before-buying/467710/?utm_source=wp-SK
Infectious disease segment held largest revenue share in 2016 and is expected to follow similar trend over the forecast timeframe due to increasing incidences of infectious diseases in developing countries of Asia Pacific and Latin America. Growing awareness about pre-disease diagnosis will fuel molecular diagnostics market growth.
Sequencing is poised to be fastest growing technological segment during the forecast timeframe owing to advancement in next-generation sequencing technology and its application in cancer diagnosis and characterization. High throughput capability along with rising automation in pre-sequencing protocols will drive molecular diagnostics market.
U.S. molecular diagnostics market held largest revenue share in 2016 due to growing geriatric population, highly susceptible to suffer from various illnesses along with high technological adoption rate of U.S. Increasing healthcare expenditure by government as well as individual will positively impact market growth.
China molecular diagnostics market should grow at significant rate due to growing demand for advanced treatment coupled with rising prevalence of infectious diseases such as hepatitis in the country. Increasing number of baby boomers will act as primary driver for industry growth. Increasing focus of industry players towards expanding country’s molecular diagnostics platform coupled with rising adoption of PCR and locally manufactured diagnostic kits in the country will favor Chine molecular diagnostics market growth.
Some of the key industry players operating in global molecular diagnostics market are Abbott, Alere, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Danaher Corporation, GenMark Diagnostics, HTG Molecular Diagnostics, Johnson & Johnson, MDxHealth, Novartis (Grifols), Qiagen Gaithersburg, Siemens Healthcare and Roche. Industry players are focusing their efforts towards developing new cost-effective, highly accurate and easy operative molecular diagnostic products to satisfy increasing consumer demand along with consolidate its market position. Strategic partnership, alliances, mergers and acquisitions are major strategies followed by market players.
Related Reports: –
Global POC Molecular Diagnostics Market 2017-2021
About POC Molecular Diagnostics POC molecular diagnostics help in identification, treatment, and prevention of infectious diseases, oncology, hematology, and prenatal diseases. The demand for POC mol…
About Us:
Centralize market research purchases across your entire organization in one place. Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
The Green Suite #4594,
Dover, DE 19901
United States
Phone: 1-201-355-0868
US Toll Free: 1-866-764-2270
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
News: https://www.marketstudyreport.com/category/news-releases/
Diagnostic Ultrasound Market by Type, Application, Element, & by Region – Global Trends and Forecast to 2022
Diagnostic Ultrasound Market is set to exceed USD 7 billion by 2024 by Market Size Forecasters Add New Global Diagnostic Ultrasound Market by Manufacturers, Countries, Type and Application, Forecast to 2024 to its research database. The report presents a deep study of the market growth factors and drivers.
Ultrasound devices are witnessing a transition from trolley based, single use systems to highly portable, versatile and multiuse systems. Rapid technological advancements in microelectronics and sensors coupled with improvement in image quality and expansion of applications will propel ultrasound system adoption rates.
Dearth of skilled ultrasound technicians and sonographers especially in countries such as UK and Canada hinder industry expansion. Lack of availability of these skilled professionals is resulting in increased patient waiting time for ultrasound examinations and underuse of the equipment.
Future Scope:
Compact or handheld ultrasound devices segment will grow at the fastest pace during the forecast period as they offer greater convenience due to their small and light weight. Furthermore, they are highly beneficial for medical professionals practicing in acute care settings where transportation of the patient may be difficult owing to the constantly changing health condition.
Application of the technology in cardiology held significant industry share. Increasing number of people suffering from cardiovascular diseases such as stroke will drive segment growth over the forecast timeframe.
Hospitals end user segment is slated to grow at a robust rate owing to increasing influx of patients undergoing ultrasound scans in these settings. Expansion of hospitals and development of new ones will further spur growth.
China diagnostic ultrasound market held significant industry share. Increasing healthcare expenditure, growing disease burden along with increasing desire for and utilization of more advanced technologies in healthcare facilities will drive industry growth.
Get Sample Copy of this Report: https://marketsizeforecasters.com/get-sample/435572/?utm_source=WRD-DC
Prominent industry players include:
GE Healthcare, Samsung, Hitachi, Siemens, Koninklijke Philips N.V., Toshiba, SIUI, Promed Group, TELEMED Medical, Mindray and Esaote. The industry participants adopt various strategies such as acquisitions, new product development and launch for expanding their industry foothold.
Diagnostic Ultrasound Market by Technology
2D
3D and 4D
Doppler
Diagnostic Ultrasound Market by Portability
Trolley
Compact / Handheld
Diagnostic Ultrasound Market by Application
General Imaging
Cardiology
Obstetrics / Gynecology
Others
Diagnostic Ultrasound Market by End Use
Hospitals
Maternity Centers
Others
Get Discount on this Report: https://marketsizeforecasters.com/enquire-for-discount/435572/?utm_source=WRD-DC
Data Tables
TABLE 1. Diagnostic ultrasound industry 360 degree synopsis, 2013 – 2024
TABLE 2. Global diagnostic ultrasound market, 2013 – 2024 (USD Million)
TABLE 3. Global diagnostic ultrasound market, by technology, 2013 – 2024 (USD Million)
TABLE 4. Global diagnostic ultrasound market, by portability, 2013 – 2024 (USD Million)
TABLE 5. Global diagnostic ultrasound market, by application, 2013 – 2024 (USD Million)
TABLE 6. Global diagnostic ultrasound market, by end use, 2013 – 2024 (USD Million)
TABLE 7. Global diagnostic ultrasound market, by region, 2013 – 2024 (USD Million)
TABLE 8. Industry impact forces
TABLE 9. 2D diagnostic ultrasound market size, by region, 2013 – 2024 (USD Million)
TABLE 10. 3D and 4D diagnostic ultrasound market size, by region, 2013 – 2024 (USD Million)
For More Detail of This Report: https://marketsizeforecasters.com/diagnostic-ultrasound-market/?utm_source=WRD-DC
Related Report
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Amblyopia Therapeutic Apparatus Market 2017 Forecast to 2022
This report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate Amblyopia Therapeutic Apparatus Market in these regions, from 2017 to 2022
About Us
MarketSizeForecasters.com, a Skyline Market Research LLP brand, is an online aggregator of market research reports. MarketSizeForecasters.com offers a comprehensive collection of full length reports on global and regional markets in 100+ industry verticals. We have partnered with some of the leading business and market research publishing houses and regularly update our online library to offer wide range of reports to our customers.
Contact Us:
Market size forecasters
The Green Suite #4594,
Dover, DE 19901
United States
Phone: 1-201-355-0868
US Toll Free: 1-866-764-2150
Email: sales@marketsizeforecasters.com
Website: http://marketsizeforecasters.com/
MarketStudyReport 
